MedDataX Logo

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

NCT05792852 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-04-24

No results posted yet for this study

Summary

This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.

Conditions

  • Disabilities Multiple

Interventions

BEHAVIORAL

ENGAGE

ENGAGE is a group intervention designed to improve social participation within the context of the COVID-19 pandemic.

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Joy Hammel, PhD · University of Illinois Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05792852 on ClinicalTrials.gov